Concepedia

Ariel Berger

AB

Statistics

Publications

51

Citations

2.6K

H-Index

25

Active since

1998

Affiliations

Policy Analysis (United States)(Current)

Pfizer (United States)

University of North Carolina at Chapel Hill

Oregon Health & Science University

Ariel Berger is an author at Policy Analysis (United States) specializing in medicine, pharmacy, and pharmacotherapy.

Publications per year

1998–2022

51

Publications

51

Clinical characteristics and economic costs of patients with painful neuropathic disorders

Ariel Berger, Ellen Dukes, Gerry Oster · Journal of Pain · 2004 · 351 citations · Full text

Medicine, Neurology, Pharmacoeconomics +16

Characteristics and healthcare costs of patients with fibromyalgia syndrome

Ariel Berger, Ellen Dukes, Susan Martin et al. · International Journal of Clinical Practice · 2007 · 335 citations · Full text

Nursing, Internal Medicine, Health Assessment +14

Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections

Nicole Bonine, Ariel Berger, Arman Altincatal et al. · The American Journal of the Medical Sciences · 2018 · 143 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +14

Adherence with Migraine Prophylaxis in Clinical Practice

Ariel Berger, Lisa Bloudek, Sepideh F. Varon et al. · Pain Practice · 2012 · 128 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +15

Clinical and Economic Consequences of Failure of Initial Antibiotic Therapy for Hospitalized Patients With Complicated Skin and Skin-Structure Infections

John Edelsberg, Ariel Berger, David J. Weber et al. · Infection Control and Hospital Epidemiology · 2007 · 117 citations

Pharmacy, Infectious Diseases, Pharmacoeconomics +10

1–5 of 51